Product information

From Health Canada

Current status:

Dormant

Current status date:

2019-08-01

Original market date: See footnote 1

1998-10-27

Product name:

FLUORESCEIN SODIUM & BENOXINATE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP

DIN:

02237775 Electronic product monograph is not available

Company:

BAUSCH & LOMB INC
1400 N Goodman Street
Rochester
New York
United States 14609

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Ophthalmic

Number of active ingredient(s):

2

Schedule(s):

Ethical

 

American Hospital Formulary Service (AHFS): See footnote 3

36:58.00  ,  52:16.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

S01JA51 FLUORESCEIN, COMBINATIONS

Active ingredient group (AIG) number:See footnote5

0207547001

List of active ingredient(s)
Active ingredient(s) Strength
BENOXINATE HYDROCHLORIDE 0.4 %
FLUORESCEIN SODIUM 0.25 %
Version 4.0.2
Date modified: